Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2020-10, Vol.34 (10), p.2820-2820
Hauptverfasser:	Ossenkoppele, G. J., Breems, D. A., Stuessi, G., van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., de Jongh, E., Klein, S. K., van der Klift, M., van Marwijk Kooy, M., Maertens, J., Michaux, L., van der Poel, M. W. M., van Rhenen, A., Tick, L., Valk, P., Vekemans, M. C., van der Velden, W. J. F. M., de Weerdt, O., Pabst, T., Manz, M., Löwenberg, B.
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1059/153 692/308/2779/109/1941 Angiogenesis inhibitors Cancer Research Correction Critical Care Medicine Hematology Intensive Internal Medicine Medicine Medicine & Public Health Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	An amendment to this paper has been published and can be accessed via a link at the top of the paper.
ISSN:	0887-6924 1476-5551
DOI:	10.1038/s41375-020-0994-7